benzene has been researched along with Recrudescence in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aplastic anemia is a bone marrow failure disorder characterized by pancytopenia and a hypocellular marrow." | 2.71 | Ex vivo immunotherapy for patients with benzene-induced aplastic anemia. ( Chen, H; Chen, J; Liu, W; Wang, X; Wu, J; Wu, L; Yang, D; Yang, Y, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 1 |
| Liu, W | 1 |
| Wang, X | 1 |
| Chen, H | 1 |
| Wu, J | 1 |
| Yang, Y | 1 |
| Wu, L | 1 |
| Yang, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I/II Study of An Ex Vivo Immunotherapy for Treatment of Idiopathic Aplastic Anemia[NCT00399971] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2002-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for benzene and Recrudescence
| Article | Year |
|---|---|
Ex vivo immunotherapy for patients with benzene-induced aplastic anemia.
Topics: Adult; Anemia, Aplastic; Benzene; Blood Cell Count; Blood Transfusion; Bone Marrow; Calcimycin; CD4- | 2003 |